CRISPR-based genome editing in primary human pancreatic islet cells. (2021)

First Author: Bevacqua RJ
Attributed to:  Targeting etiologic molecular mechanisms to treat human diabetes funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-021-22651-w

PubMed Identifier: 33893274

Publication URI: http://europepmc.org/abstract/MED/33893274

Type: Journal Article/Review

Volume: 12

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723